http://www.biospace.comBioSpace RSS GeneratorWed, 19 Jun 2013 14:23:06 GMT20http://rss.biospace.com/images/BSPLogo.gifhttp://www.BioSpace.com/news.aspx?SectionId=1Copyright (C) 2011http://www.biospace.com/news_story.aspx?StoryID=287956&full=1SAND DIEGO and VANCOUVER, Feb. 18, 2013 - Sophiris Bio Inc. (Sophiris, TSX: SHS) ("Sophiris" or the "Company"), a biopharmaceutical company developing a treatment for benign prostatic hyperplasia (BPH or enlarged prostate), previously announced on February 15, 2013 that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial...Tue, 19 Feb 2013 12:00:00 AM GMThttp://www.renaissancecapital.com/ipohome/news/China-based-biotech-Newsummit-Biopharma-files-for-$80-million-US-IPO-11121.htmlFebruary 25, 2012 -- Newsummit Biopharma Holdings, a Shanghai-based CRO offering pre-clinical drug development services, filed to raise up to $80 million in a New York Stock Exchange IPO. The company has offices in five technology parks around China. Newsummit aims to be a one-stop solution for bringing a drug candidate or medical device through an IND (or NDA) filing, after the initial work on the...Mon, 27 Feb 2012 12:00:00 AM GMThttp://www.streetinsider.com/IPOs/Cathay+Industrial+Biotech+(CBIO)+Files+$200M+IPO/6646955.htmlCathay Industrial Biotech Ltd. (Nasdaq: CBIO) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of it's American Depositary Shares, or ADSs. The proposed maximum offering price is $200 million. Cathay filed to list on the New York Stock Exchange under the ticker "CBIO." The offering is being made through Morgan Stanley, Deutsche Bank, and Jefferies...Wed, 20 Jul 2011 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20101123November 23, 2010 -- Beijing Pharmaceutical, a subsidiary of China Resources Medications Group, plans to list on the Hong Kong Stock Exchange, one more piece of evidence that Hong Kong is the exchange of choice for large China pharma IPOs. As yet, the size of the offering is not known. However, Beijing Pharmas revenues are expected to hit 16 billion RMB ($2.4 billion) in 2010, up from 10 billion ...Tue, 23 Nov 2010 12:00:00 AM GMThttp://www.tradingmarkets.com/news/stock-alert/ms_m-stanley-ubs-to-arrange-china-sihuan-pharmaceutical-s-ipo-1205918.htmlReuters -- Sihuan Pharmaceutical Holdings Group Ltd, China's largest cardio-cerebral vascular drugmaker, plans to raise $600-700 million from a Hong Kong initial public offering this month, sources familiar with the matter told Reuters on Monday, joining a flurry of stock offerings in the city in recent months.Mon, 04 Oct 2010 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idINT36292820080703?rpc=44TOKYO, July 3 (Reuters) - RaQualia, a pharma venture that was recently spun off by drug maker Pfizer Inc (PFE.N: Quote, Profile, Research, Stock Buzz), aims to go public by the first quarter of 2011, its president said on Thursday.Thu, 03 Jul 2008 12:00:00 AM GMT